Healthcare use after screening for lung cancer

Margaret M Byrne, Tulay Sengul, Wei Zhao, Joel L. Weissfeld, Mark S. Roberts

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

BACKGROUND: To evaluate the benefits of lung cancer screening, all effects of screening need to be considered. The aim of this study was to determine whether screening had an effect on healthcare use, specifically whether use increased for those with a false-positive or indeterminate screening result. METHODS: Recruited were 400 individuals participating in a lung cancer screening study at the University of Pittsburgh. Self-reported outpatient healthcare use information was collected for the 6 months before, 0 to 6 months after, and 6 to 12 months after screening. The screening outcomes were negative, indeterminate, and suspicious. Repeated-measures Poisson regression models were used to examine changes in use over time and how changes over time varied among the screening outcome groups. RESULTS: Approximately 58% of participants had a negative screening result, 36% had an indeterminate result, and approximately 6% had a suspicious result. The percentage of individuals who had any incidence of each type of outpatient use increased after screening, with the greatest increase noted for those with a suspicious screening result. Adjusted mean use significantly increased for nearly all types of use and for all 3 screening results categories in the 6 months after screening, but mostly declined to prescreening levels in the next 6 months. CONCLUSIONS: Outpatient healthcare use was found to increase after screening for all individuals who were screened for lung cancer, regardless of the screening finding. The cost of the lung-related visits alone was substantial. Therefore, if lung cancer screening prevalence is increased, attendant follow-up healthcare costs are also likely to increase.

Original languageEnglish
Pages (from-to)4793-4799
Number of pages7
JournalCancer
Volume116
Issue number20
DOIs
StatePublished - Dec 1 2010

Fingerprint

Early Detection of Cancer
Lung Neoplasms
Delivery of Health Care
Outpatients
Health Care Costs
Costs and Cost Analysis
Lung
Incidence

Keywords

  • Costs
  • Healthcare use
  • Lung cancer
  • Screening
  • Survey

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Byrne, M. M., Sengul, T., Zhao, W., Weissfeld, J. L., & Roberts, M. S. (2010). Healthcare use after screening for lung cancer. Cancer, 116(20), 4793-4799. https://doi.org/10.1002/cncr.25466

Healthcare use after screening for lung cancer. / Byrne, Margaret M; Sengul, Tulay; Zhao, Wei; Weissfeld, Joel L.; Roberts, Mark S.

In: Cancer, Vol. 116, No. 20, 01.12.2010, p. 4793-4799.

Research output: Contribution to journalArticle

Byrne, MM, Sengul, T, Zhao, W, Weissfeld, JL & Roberts, MS 2010, 'Healthcare use after screening for lung cancer', Cancer, vol. 116, no. 20, pp. 4793-4799. https://doi.org/10.1002/cncr.25466
Byrne MM, Sengul T, Zhao W, Weissfeld JL, Roberts MS. Healthcare use after screening for lung cancer. Cancer. 2010 Dec 1;116(20):4793-4799. https://doi.org/10.1002/cncr.25466
Byrne, Margaret M ; Sengul, Tulay ; Zhao, Wei ; Weissfeld, Joel L. ; Roberts, Mark S. / Healthcare use after screening for lung cancer. In: Cancer. 2010 ; Vol. 116, No. 20. pp. 4793-4799.
@article{b140caf487aa45d78380c3cdc81d368f,
title = "Healthcare use after screening for lung cancer",
abstract = "BACKGROUND: To evaluate the benefits of lung cancer screening, all effects of screening need to be considered. The aim of this study was to determine whether screening had an effect on healthcare use, specifically whether use increased for those with a false-positive or indeterminate screening result. METHODS: Recruited were 400 individuals participating in a lung cancer screening study at the University of Pittsburgh. Self-reported outpatient healthcare use information was collected for the 6 months before, 0 to 6 months after, and 6 to 12 months after screening. The screening outcomes were negative, indeterminate, and suspicious. Repeated-measures Poisson regression models were used to examine changes in use over time and how changes over time varied among the screening outcome groups. RESULTS: Approximately 58{\%} of participants had a negative screening result, 36{\%} had an indeterminate result, and approximately 6{\%} had a suspicious result. The percentage of individuals who had any incidence of each type of outpatient use increased after screening, with the greatest increase noted for those with a suspicious screening result. Adjusted mean use significantly increased for nearly all types of use and for all 3 screening results categories in the 6 months after screening, but mostly declined to prescreening levels in the next 6 months. CONCLUSIONS: Outpatient healthcare use was found to increase after screening for all individuals who were screened for lung cancer, regardless of the screening finding. The cost of the lung-related visits alone was substantial. Therefore, if lung cancer screening prevalence is increased, attendant follow-up healthcare costs are also likely to increase.",
keywords = "Costs, Healthcare use, Lung cancer, Screening, Survey",
author = "Byrne, {Margaret M} and Tulay Sengul and Wei Zhao and Weissfeld, {Joel L.} and Roberts, {Mark S.}",
year = "2010",
month = "12",
day = "1",
doi = "10.1002/cncr.25466",
language = "English",
volume = "116",
pages = "4793--4799",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "20",

}

TY - JOUR

T1 - Healthcare use after screening for lung cancer

AU - Byrne, Margaret M

AU - Sengul, Tulay

AU - Zhao, Wei

AU - Weissfeld, Joel L.

AU - Roberts, Mark S.

PY - 2010/12/1

Y1 - 2010/12/1

N2 - BACKGROUND: To evaluate the benefits of lung cancer screening, all effects of screening need to be considered. The aim of this study was to determine whether screening had an effect on healthcare use, specifically whether use increased for those with a false-positive or indeterminate screening result. METHODS: Recruited were 400 individuals participating in a lung cancer screening study at the University of Pittsburgh. Self-reported outpatient healthcare use information was collected for the 6 months before, 0 to 6 months after, and 6 to 12 months after screening. The screening outcomes were negative, indeterminate, and suspicious. Repeated-measures Poisson regression models were used to examine changes in use over time and how changes over time varied among the screening outcome groups. RESULTS: Approximately 58% of participants had a negative screening result, 36% had an indeterminate result, and approximately 6% had a suspicious result. The percentage of individuals who had any incidence of each type of outpatient use increased after screening, with the greatest increase noted for those with a suspicious screening result. Adjusted mean use significantly increased for nearly all types of use and for all 3 screening results categories in the 6 months after screening, but mostly declined to prescreening levels in the next 6 months. CONCLUSIONS: Outpatient healthcare use was found to increase after screening for all individuals who were screened for lung cancer, regardless of the screening finding. The cost of the lung-related visits alone was substantial. Therefore, if lung cancer screening prevalence is increased, attendant follow-up healthcare costs are also likely to increase.

AB - BACKGROUND: To evaluate the benefits of lung cancer screening, all effects of screening need to be considered. The aim of this study was to determine whether screening had an effect on healthcare use, specifically whether use increased for those with a false-positive or indeterminate screening result. METHODS: Recruited were 400 individuals participating in a lung cancer screening study at the University of Pittsburgh. Self-reported outpatient healthcare use information was collected for the 6 months before, 0 to 6 months after, and 6 to 12 months after screening. The screening outcomes were negative, indeterminate, and suspicious. Repeated-measures Poisson regression models were used to examine changes in use over time and how changes over time varied among the screening outcome groups. RESULTS: Approximately 58% of participants had a negative screening result, 36% had an indeterminate result, and approximately 6% had a suspicious result. The percentage of individuals who had any incidence of each type of outpatient use increased after screening, with the greatest increase noted for those with a suspicious screening result. Adjusted mean use significantly increased for nearly all types of use and for all 3 screening results categories in the 6 months after screening, but mostly declined to prescreening levels in the next 6 months. CONCLUSIONS: Outpatient healthcare use was found to increase after screening for all individuals who were screened for lung cancer, regardless of the screening finding. The cost of the lung-related visits alone was substantial. Therefore, if lung cancer screening prevalence is increased, attendant follow-up healthcare costs are also likely to increase.

KW - Costs

KW - Healthcare use

KW - Lung cancer

KW - Screening

KW - Survey

UR - http://www.scopus.com/inward/record.url?scp=78349273597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78349273597&partnerID=8YFLogxK

U2 - 10.1002/cncr.25466

DO - 10.1002/cncr.25466

M3 - Article

VL - 116

SP - 4793

EP - 4799

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 20

ER -